Abstract: Technologies for generating a graphical user interface (GUI) dashboard with a three-dimensional (3D) grid of unit cells are described. An anomaly statistic can be determined for a set of records. A subset of network address identifiers can be identified and sorted according to the anomaly statistic. The subset can have higher anomaly statistics than other network address identifiers. There can be a maximum number in the subset. The GUI dashboard is generated with unit cells organized by the subset of network address identifiers as rows, time intervals as columns, colors as a configurable anomaly score indicator, and a number of network access events as column heights. Each unit cell is a colored, 3D visual object representing a composite score of anomaly scores associated with zero or more network access events corresponding to the respective network address identifier at the respective time interval. The GUI dashboard is rendered on a display.

Abstract: Technologies for generating a set of models for each account, where each model is a fine-grained, unsupervised behavior model trained for each user to monitor and detect anomalous patterns are described. An unsupervised training pipeline can generate user models, each being associated with one of multiple accounts and is trained to detect an anomalous pattern using feature data associated with the one account. Each account is associated with at least one of a user, a machine, or a service. An inference pipeline can detect a first anomalous pattern in first data associated with a first account using a first user model. The inference pipeline can detect a second anomalous pattern in second data associated with a second account using a second user model.

Abstract: The present disclosure relates to a method of providing prolonged analgesia to a mammal in need thereof. Specifically, the current disclosure is directed to a method of treating pain in a mammal for a prolonged period of time using a single high dose of a buprenorphine formulation.

Abstract: The present disclosure relates to a method of providing prolonged analgesia to a mammal in need thereof. Specifically, the current disclosure is directed to a method of treating pain in a mammal for a prolonged period of time using a single high dose of a buprenorphine formulation.

Abstract: The invention provides a composition comprising a hydrophilic colloid and a surface active agent characterised in that the surface active agent is a compound having the formula ##STR1## wherein each of R.sub.1, R.sub.2 and R.sub.3 independently is a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group;each of X and Y is --H or --Q.sup.- M.sup.+ ;Q.sup.- is an anion; and,M.sup.+ is a cation;provided that when X is --H, Y is --Q.sup.- M.sup.+ and that when X is --Q.sup.- M.sup.+, Y is --H.Preferred surface active agents include compounds of the above formula wherein R.sub.1, R.sub.2 and R.sub.3 are identical.The anion Q.sup.- is a negatively charged atom or group of atoms preferably comprising a sulphonate group, such as --SO.sub.3.sup.- or --CH.sub.2 SO.sub.3.sup.- or a sulphate group, such as --OSO.sub.3.sup.-.The cation M.sup.+ is a positively charged atom or group of atoms preferably chosen from alkali metal cations, such as Na.sup.+ or ammonium.